Research conducted by Trujillo’s team in 2011 [43] assessed the frequency and functional response of innate immune cells in peripheral blood from CVID patients and healthy controls after activation with TLR2 agonists, TLR4, and TLR9. The gene discussed is TLR9; the disease is common variable immunodeficiency.